• Oriflame’s third-quarter 2026 sales fell 23% to EUR 97.6 million, with the decline also reaching 23% in local currencies.
• The active community contracted 26% to 1,020,000 at quarter-end.
• Adjusted EBITDA was negative EUR 1.5 million, with an adjusted EBITDA margin of -1.5% as lower volumes drove operating deleverage.
• Gross margin rose to 66.3% from 65.7%, supported by favorable pricing and product mix.
• Adjusted cash flow before financing reached EUR 3.7 million; the closing cash balance stood at EUR 23.2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oriflame Cosmetics Global SA published the original content used to generate this news brief on October 23, 2026, and is solely responsible for the information contained therein.